COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.
Andrea MatucciMarco CaminatiEmanuele VivarelliAndrea VianelloClaudio MichelettoFrancesco MenzellaErnesto CrisafulliGiovanni PassalacquaDiego BagnascoCarlo LombardiPaola ParronchiMariaangiola A CrivellaroFulvia Chieco-BianchiMaria Rita MarchiGabriella GuarnieriLorenzo CosmiOliviero RossiFabio AlmerigognaGianenrico SennaAlessandra VultaggioPublished in: Allergy (2020)
Keyphrases
- end stage renal disease
- coronavirus disease
- sars cov
- ejection fraction
- newly diagnosed
- oxidative stress
- chronic kidney disease
- cross sectional
- prognostic factors
- early onset
- cancer therapy
- lung function
- cystic fibrosis
- patient reported outcomes
- drug delivery
- chronic obstructive pulmonary disease
- drug induced
- smoking cessation